Učitavanje...

DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy

PEGylated liposomes have transformed chemotherapeutic use of doxorubicin by reducing its cardiotoxicity; however, it remains unclear whether liposomal doxorubicin is therapeutically superior to free doxorubicin. Here, we demonstrate a novel PEGylated liposome system, named DAFODIL (Doxorubicin And 5...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Control Release
Glavni autori: Camacho, Kathryn M., Menegatti, Stefano, Vogus, Douglas R., Pusuluri, Anusha, Fuchs, Zoë, Jarvis, Maria, Zakrewsky, Michael, Evans, Michael A., Chen, Renwei, Mitragotri, Samir
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5289372/
https://ncbi.nlm.nih.gov/pubmed/27034194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2016.03.027
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!